Back to Results
First PageMeta Content
Vaccines / Influenza A virus subtype H5N1 / Epidemiology / Pandemics / Influenza A virus subtype H1N1 / Influenza vaccine / Flu pandemic vaccine / Flu pandemic / AS03 / Influenza / Medicine / Health


Microsoft PowerPoint - 29FebVRBPAC_28Feb2012
Add to Reading List

Open Document

File Size: 313,23 KB

Share Result on Facebook

Company

BARDA / GSK / Glaxosmithkline plc / /

Country

Indonesia / United States / Canada / /

Event

FDA Phase / Business Partnership / /

IndustryTerm

oil-in-water emulsion / /

MedicalCondition

disease / influenza A / /

MedicalTreatment

active immunization / Vaccination / /

Organization

National Institute of Health / World Health Organization / /

Person

Katalin Abraham / /

/

Position

Director / US Regulatory Affairs GSK Biologicals / Director / US Regulatory Affairs GSK Biologicals GSK’s Influenza Vaccines in Dresden Process Québec Process Vaccine In Development Trivalent / /

Product

AS03 adjuvant system / AS03 / FluLaval / Fluarix® / H1N1 / H5N1 Vaccine / Submitted / H5N1 / Adjuvanted Pandemic Influenza / FluLaval® Submitted / /

ProgrammingLanguage

J / C / /

SocialTag